FDA’s Mobile Health Guidance Removes Risk For Investors

Investors and their limited partners really don’t like risk, especially not the kind due to uncertainty. Now, for developers of mobile health applications and their investors, at least one risk has been taken off the table: regulatory uncertainty. On September 23, the FDA published the much-anticipated final guidance on mobile medical apps.

In 1889, the passing of an appropriations bill paved the way for the famous Oklahoma Land Rush, creating the cities of Oklahoma City and Guthrie in just one day. The US Food and Drug Administration’s finalization of highly anticipated guidelines on the regulation of mobile health apps might have a similar impact on the mobile health community.

Investors and entrepreneurs have been standing at the border of the health care’s new unsettled territory, waiting for some law of the land that would create regulatory clarity. According to...

More from Regulation

More from Policy & Regulation